domingo, 6 de octubre de 2013

CDC - Morbidity and Mortality Weekly Report (MMWR)

CDC - Morbidity and Mortality Weekly Report (MMWR)

MMWR Recommendations and Reports

September 27, 2013 / Vol. 62 / No. RR–8
CE Available

Investigating Suspected Cancer Clusters and Responding to Community Concerns: Guidelines from CDC and the Council of State and Territorial Epidemiologists

This report provides guidelines from CDC and the Council of State and Territorial Epidemiologists for investigating suspected cancer clusters in a residential or community setting. State and local health departments can use these guidelines to develop a systematic approach to responding to community concerns regarding cancer clusters.

MMWR Surveillance Summaries

July 19, 2013 / Vol. 62 / No. SS–3
Surveillance for Travel-Related Disease — GeoSentinel Surveillance System, United States, 1997–2011

GeoSentinel is a clinic-based global surveillance system that tracks infectious diseases and other adverse health outcomes in returned travelers, foreign visitors, and immigrants. This report discusses data that were collected during September 1997–December 2011 on 141,789 patients with confirmed or probable travel-related diagnoses. Health-care providers should help prepare travelers properly for safe travel and provide destination-specific medical evaluation of returning ill travelers. These efforts, including proper training, should focus on preventing and treating a variety of travel-related conditions, particularly traveler’s diarrhea and malaria.

MMWR Summary of Notifiable Diseases

July 5, 2013 / Vol. 60 / No. 53
Summary of Notifiable Diseases — United States, 2011

Health-care providers in the United States are required to report certain infectious diseases to a specified state or local authority. A disease is designated as notifiable if timely information about individual cases is considered necessary for prevention and control of the disease. Each year, CDC publishes a summary of the cases of notifiable disease reported for the most recent year for which data is available. This report presents a summary of notifiable diseases for 2011.

MMWR Supplements

May 17, 2013 / Vol. 62 / Supplement / No. 2
Mental Health Surveillance Among Children — United States, 2005–2011

This report summarizes information about ongoing federal surveillance systems that can provide estimates of the prevalence of mental disorders and indicators of mental health among children living in the United States and presents estimates of childhood mental disorders and indicators from these systems during 2005–2011. Attention-deficit/hyperactivity disorder (6.8%) was the most prevalent parent-reported current diagnosis among children aged 3–17 years, followed by behavioral or conduct problems (3.5%), anxiety (3.0%), depression (2.1%), autism spectrum disorders (1.1%), and Tourette syndrome (0.2% among children aged 6–17 years). An estimated 4.7% of adolescents aged 12–17 years reported an illicit drug use disorder in the past year, 4.2% had an alcohol abuse disorder in the past year, and 2.8% had cigarette dependence in the past month. The overall suicide rate for persons aged 10–19 years was 4.5 suicides per 100,000 persons in 2010. Approximately 8% of adolescents aged 12–17 years reported ≥14 mentally unhealthy days in the past month.

Child and Adult Immunization Schedules

February 1, 2013 / Vol. 62
Advisory Committee on Immunization Practices (ACIP) Recommended Immunization Schedules for Persons Aged 0 Through 18 Years and Adults Aged 19 Years and Older — United States, 2013

Each year, recommendations for routine use of vaccines in children, adolescents, and adults in the United States are developed by the Advisory Committee on Immunization Practices (ACIP). This year, for the first time, recommended immunization schedules for persons aged 0 through 18 years and adults aged 19 years and older are being published together. Health-care providers are advised to use both the recommended schedules for children and adults in combination with their footnotes and not as stand-alones. For guidance on the use of all the vaccines in the schedules, including contraindications and precautions to use of a vaccine, providers are referred to the respective ACIP vaccine recommendations.
Download Issue Adobe PDF file

No hay comentarios: